Clinical Trial Update: Bioequivalence Study of Montelukast 5 mg Chewable [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study of Montelukast 5 mg chewable tablets for asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast 5 mg chewable (montelukast)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED